Filing Details

Accession Number:
0000950170-24-067305
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-31 16:07:36
Reporting Period:
2024-05-29
Accepted Time:
2024-05-31 16:07:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1563880 Trevi Therapeutics Inc. TRVI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1229946 Thomas Sciascia C/O Trevi Therapeutics, Inc.
195 Church Street, 16Th Floor
New Haven CT 06510
Chief Scientific Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-05-29 59,354 $2.19 267,801 No 4 M Direct
Common Stock Disposition 2024-05-29 53,368 $2.55 214,433 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2024-05-29 59,354 $0.00 59,354 $2.19
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2024-07-01 No 4 M Direct
Footnotes
  1. Includes 14,723 shares purchased through the Issuer's employee stock purchase plan.
  2. This sale represents the sale of shares necessary to cover the cost of exercise and to meet tax withholding obligations as a result of the exercise of stock options on May 29, 2024.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.55 to $2.56 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  4. This option was granted on July 2, 2014. The 59,354 shares of common stock underlying the option vested as to 25% of the shares on June 11, 2015 and vested as to the remaining 75% of the shares in equal monthly installments thereafter through June 11, 2018.